Arcturus Therapeutics Holdings Inc. (ARCT) financial statements (2021 and earlier)

Company profile

Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO, CA 92121
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2019
Q1
12/31/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31 
Cash and cash equivalents31 
Receivables4 
Prepaid expense1 
Other current assets0 
Total current assets:37 
Noncurrent Assets
Property, plant and equipment2 
Restricted cash and investments0 
Other undisclosed noncurrent assets6 
Total noncurrent assets:8 
TOTAL ASSETS:44 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7 
Accounts payable4 
Accrued liabilities3 
Other undisclosed current liabilities8 
Total current liabilities:15 
Noncurrent Liabilities
Long-term debt and lease obligation10 
Long-term debt, excluding current maturities10 
Other undisclosed noncurrent liabilities14 
Total noncurrent liabilities:23 
Total liabilities:38 
Stockholders' equity
Stockholders' equity attributable to parent6 
Common stock0 
Additional paid in capital59 
Accumulated deficit(53) 
Total stockholders' equity:6 
TOTAL LIABILITIES AND EQUITY:44 

Income statement (P&L) ($ in millions)

3/31/2019
Q1
12/31/2018
Q4
Gross profit:4 
Operating expenses(11) 
Operating loss:(7) 
Nonoperating expense
(Other Nonoperating expense)
(0) 
Loss from continuing operations before equity method investments, income taxes:(7) 
Loss from equity method investments(0) 
Net loss available to common stockholders, diluted:(7) 

Comprehensive Income ($ in millions)

3/31/2019
Q1
12/31/2018
Q4
Net loss:(7) 
Comprehensive loss, net of tax, attributable to parent:(7) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: